Investing In America
- The Chairman
- Apr 27
- 1 min read
Roche, a Swiss drug and diagnostics company, announced a $50 billion investment in its U.S.-based manufacturing and R&D, which is expected to create more than 1,000 new full-time jobs and more than 12,000 jobs including construction.
Regeneron Pharmaceuticals, Inc., a leader in biotechnology, announced a $3 billion agreement with Fujifilm Diosynth Biotechnologies to produce drugs at its North Carolina manufacturing facility.
NorthMark Strategies, a multi-strategy investment firm, announced a $2.8 billion investment to build a supercomputing facility in South Carolina.
Please open and view the following: https://www.youtube.com/watch?v=EzrBCd_fMRU&t=183s&pp=ygUfYm9iIHN1dHRvbiBpbnZlc3RpbmcgaW4gYW1lcmljYQ%3D%3D
#EconomicGrowth#JobCreation#BiotechInnovation#ManufacturingExpansion#Pharmaceuticals#ResearchAndDevelopment#RocheInvestment#Regeneron#FujifilmDiosynth#NorthCarolinaJobs#SouthCarolinaDevelopment#Supercomputing#TechInvestment#HealthcareInnovation#AmericanManufacturing#InfrastructureBoom#BiotechBoom#FutureOfMedicine#InvestmentInAmerica#USJobs#bobsuttonbroward #chairmanbobsutton
Comments